Emory Helps Establish National Standard of Care for COVID-19 Treatment
October 16, 2020
October 16, 2020
ATLANTA, Georgia, Oct. 16 (TNSJou) -- Emory University's Woodruff Health Sciences Center issued the following news release:
Final results of an international study in adults hospitalized with COVID -19 show that treatment with the experimental antiviral drug remdesivir resulted in faster recovery, fewer days on oxygen and lower progression to ventilation compared with placebo.
The results of the National Institute of Allergy and Infectious Diseases-sponsored ACTT- . . .
Final results of an international study in adults hospitalized with COVID -19 show that treatment with the experimental antiviral drug remdesivir resulted in faster recovery, fewer days on oxygen and lower progression to ventilation compared with placebo.
The results of the National Institute of Allergy and Infectious Diseases-sponsored ACTT- . . .